Search - tctmd.com

Displaying 361 - 380 of 603

Sort: Relevancy | Date

Presentation TCT 2017

Next Generation Bio Innovation

Presenter: Andreu M Climent, Amit N. Patel

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Presenter: Andreu M Climent, Amit N. Patel, Angel Arenal

October 31, 2017

Presentation TCT 2017

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

Presenter: Andreu M Climent, Amit N. Patel, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Presenter: Andreu M Climent, Amit N. Patel, Gary L. Schaer

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD

October 31, 2017

Presentation TCT 2017

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

The American Vision of Regenerative Cardiovascular Medicine

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles, Jens Kastrup

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Blood in Urine Carries Consequences for Patients on Antithrombotics

Yael L. Maxwell

October 09, 2017

News Daily News

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Todd Neale

October 04, 2017

News Daily News

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

Todd Neale

September 25, 2017

News Daily News

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

Michael O'Riordan

September 22, 2017

Advertisement

Next Generation Bio Innovation

Off Script: Focusing on the Future

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

The American Vision of Regenerative Cardiovascular Medicine

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Blood in Urine Carries Consequences for Patients on Antithrombotics

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content